FDA Targets Blood-Zapping Devices in Cancer Fight
Published Date: 3/18/2026
Proposed Rule
Summary
The FDA is planning to require companies that make blood irradiators used during cancer surgeries to get special approval before selling them. This change helps make sure these devices are safe and effective in preventing cancer spread. If finalized, manufacturers will have about 30 months to submit their approval applications, so they should get ready soon!
Analyzed Economic Effects
4 provisions identified: 0 benefits, 3 costs, 1 mixed.
PMA requirement for blood irradiators
If finalized, manufacturers of blood irradiators used to irradiate intraoperatively salvaged blood to help prevent metastasis must file a premarket approval (PMA). The PMA must be filed by the last day of the 30th calendar month after the device is classified into class III.
Market removal and investigational use rules
If a PMA is not timely filed, the device could be deemed adulterated and subject to enforcement, and manufacturers must stop distribution if a PMA is denied. Devices may only be distributed for investigational use under an approved investigational device exemption (IDE).
PMA must include clinical evidence and testing
FDA requires a PMA to include valid scientific evidence, full preclinical and clinical reports, and performance testing showing reasonable assurance of safety and effectiveness. FDA also encourages early meetings via the Q-Submission Program and recommends submitting an IDE at least 30 days before the PMA filing date to avoid interrupting investigations.
Short review window, continued marketing if timely filed
FDA says it intends to review any PMA for these devices within 180 days. A device that was in commercial distribution before May 28, 1976 (or found substantially equivalent by that date) may remain on the market during FDA's PMA review if a PMA is filed on time.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food
The Food and Drug Administration (FDA or the Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's third-party disclosure and recordkeeping requirements for reportable food.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16715, Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2026-05320, Medical Devices; Radiology Devices; Classification of Blood Irradiators
The FDA is proposing new rules to make blood irradiators safer and more reliable. Devices that stop a serious transfusion problem will need a simpler review, while those aimed at preventing cancer spread will face a tougher approval process. If you make or use these devices, get ready to comment by May 18, 2026, and expect some extra costs for the stricter reviews.
Next: 2026-05327, Airworthiness Directives; The Boeing Company Airplanes
If you fly or fix Boeing 787 planes, listen up! The FAA wants to update safety rules by swapping out a part on the wing’s leading edge to keep flights safer and add new maintenance checks. These changes keep all the old safety steps but add new ones, and comments are open until May 4, 2026—so there’s time to weigh in before any costs or work changes kick in.